A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion

Open Access

Peer-reviewed

Research Article

Felix Scheuplein ,

* E-mail: FScheuplein@NKTRX.com

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯
Abraham Thariath,

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯
Susan Macdonald,

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯
Alemseged Truneh,

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯
Robert Mashal,

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯
Robert Schaub

Affiliation NKT Therapeutics, Inc., Waltham, Massachusetts, United States of America
⨯

Reader Comments (0)

Macaque
Is the Subject Area "Macaque" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.
Monkeys
Is the Subject Area "Monkeys" applicable to this article?

Thanks for your feedback.
Primates
Is the Subject Area "Primates" applicable to this article?

Thanks for your feedback.
T cell receptors
Is the Subject Area "T cell receptors" applicable to this article?

Thanks for your feedback.